KJHP
AYTU icon

K.J. Harrison & Partners’s AYTU BioPharma AYTU Stock Holding History

K.J. Harrison & Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-51
Closed -$53K – 195
2018
Q2 		$53K Hold
51
– – 0.02% 179
2018
Q1 		$129K Buy
+51
New +$351K 0.04% 156

Other funds holding AYTU

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

K.J. Harrison & Partners's AYTU Position: Q3 2018 in Review

K.J. Harrison & Partners sold out of AYTU BioPharma (AYTU) in Q3 2018, closing a stake of 51 shares — an estimated $53K sold.

K.J. Harrison & Partners first reported a position in AYTU in Q1 2018 and held it in 2 quarters. The position peaked at $129K in Q1 2018. 8 funds tracked by Wall St. Rank hold AYTU as of Q3 2018.

  • K.J. Harrison & Partners reported no remaining AYTU BioPharma position as of Q3 2018 after selling out during the quarter.
  • K.J. Harrison & Partners sold 51 AYTU BioPharma shares in Q3 2018, an estimated $53K.
  • K.J. Harrison & Partners first reported a position in AYTU BioPharma in Q1 2018 and held it in 2 quarters.
  • K.J. Harrison & Partners's AYTU BioPharma position peaked at $129K in Q1 2018.
  • 8 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2018.

Based on K.J. Harrison & Partners's 13F filing for Q3 2018, filed 26 Oct 2018.